Developing the pharmaceutical product offering
Our insights and recommendations will give you the confidence to make the right strategic decisions as you develop the pharmaceutical product offering
Active compounds are developed into patented products for testing in clinical trials and investigational new drug applications are made with relevant regulatory bodies for approval. At this stage (around Phase III), marketing measures are developed to support the pharmaceutical product offering, covering such areas as the target product profile, market forecasting and preliminary positioning.
Key questions which need to be answered at this stage include:
- What is the best way to design clinical trials?
- What is the market opportunity?
- What is the likely size of the market segment?
- What should the product be named?
- What should be the general positioning for this product?
Our custom pharmaceutical market research offerings include:
- Clinical trial design evaluation
- Market opportunity assessment
- Name testing
- Market positioning
- How we assessed the opportunity for a rare disease product in emerging markets
The challenge:Our client had a product indicated for a rare Haematology disease. Whilst this product was successfully launched in over 40 countries globally, it had a limited presence in many emerging markets. Our client needed to conduct market research in order to determine how to maximise the commercial opportunities in each of these different emerging markets. The solution:A three-phase methodology was utilised. A definition phase…read more »How we evaluated the potential for an existing AI product to treat a rare disease
The challenge:Our client had an existing product in the market for the treatment of an autoimmune condition and wished to explore the opportunities for using this drug to treat another more low-prevalence orphan disease where there is no current targeted treatment available. The client wished to determine the market potential for the existing drug and the challenges they may face. The solution:Interviews were held with…read more »How research supported the design of a support console to drive new product uptake
The situationOur client was developing a console system to support a new ophthalmology drug delivery system. They wanted to carry out research in order to discover physicians’ suggestions for the current prototype console and the potential barriers and drivers that may affect uptake, prior to initiating full development of the system. The solutionA qualitative approach was utilised in order to focus on the exploration of the key…read more »How buyer insights supported the development of an effective market strategy
The challengeOur client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India. They needed to understand how new medicines are added to the guidelines and how they are evaluated and funded. They also needed to gain an understanding of stakeholders’ reactions to their product, the drivers and barriers to…read more »
- Some example case studiesHow we uncovered unmet needs using social media listening
The challenge: Our client wanted to further their understanding of the impacts a long-term rare skin condition can have on patients by exploring the patient journey. Market research was required to identify opportunities for improving the patient experience and inform the brand strategy for their product. The solution: We began by conducting exploratory research using social media listening to review the online commentary and get…read more »How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market
The challengeOur client had their product for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering…read more »How we helped assess the asthma market landscape in emerging markets
The challengeOur client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. In order to prepare for launch, primary and secondary market research was required to understand more fully the asthma landscape. The solutionWe investigated the asthma landscape in 12 global emerging markets: Argentina, Brazil, China, Colombia, Hong Kong, Israel, Mexico, Russia, Saudi Arabia, Taiwan, Turkey, UAE. We conducted…read more »